Ayala Pharmaceuticals Valor Contábil/Ação
Qual é o Valor Contábil/Ação de Ayala Pharmaceuticals?
O Valor Contábil/Ação de Ayala Pharmaceuticals Inc. é 5.20
Qual é a definição de Valor Contábil/Ação?
O valor contábil por ação é um ativo da empresa menos as responsabilidades dividido pelo número de ações em circulação.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor Contábil/Ação de empresas na Setor Health Care em NASDAQ em comparação com Ayala Pharmaceuticals
O que Ayala Pharmaceuticals faz?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Empresas com valor contábil/ação semelhantes a Ayala Pharmaceuticals
- Duff & Phelps Select MLP and Midstream Fund Inc tem Valor Contábil/Ação de 5.20
- X-FAB Silicon Foundries SE tem Valor Contábil/Ação de 5.20
- Estee Lauder Cos tem Valor Contábil/Ação de 5.20
- China Zhongwang tem Valor Contábil/Ação de 5.20
- Syncora tem Valor Contábil/Ação de 5.20
- Bank Of South Carolina tem Valor Contábil/Ação de 5.20
- Ayala Pharmaceuticals tem Valor Contábil/Ação de 5.20
- Canadian Net Real Estate Investment Trust tem Valor Contábil/Ação de 5.21
- Corticeira Amorim SGPS SA tem Valor Contábil/Ação de 5.21
- FAX Capital tem Valor Contábil/Ação de 5.21
- China Customer Relations Centers Inc tem Valor Contábil/Ação de 5.21
- Elate tem Valor Contábil/Ação de 5.21
- Elders tem Valor Contábil/Ação de 5.22